(R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, 95.0%, 25g

Ethylenediaminetetraacetic acid, disodium salt dihydrate, ACS reagent, 99%, 1g

6-Bromo-2,3-dihydro-1H-inden-1-ol, 95.0%, 25g

2,2'-(Piperazine-1,4-diyl)bis(N-methyl-N-(4-nitrophenyl)acetamide) (Nintedanib Impurity), 97%, 50mg

(2-FLUORO-3-METHOXYPYRIDIN-4-YL)BORONIC ACID, 95.0%, 250mg

6-(2-Chloro-5-fluoropyrimidin-4-yl)-1-cyclopropyl-4-fluoro-2-methyl-1H-benzo[d]imidazole, 98%, 5g

8-Chloro-1,2,3,4-tetrahydroquinoline, 95.0%, 1g

4,5-Dichloropyrimidin-2-amine, 95.0%, 250mg

Methyl 4-bromo-5-methylpyrazolo[1,5-a]pyridine-3-carboxylate, 98%, 250mg

2,4,6-Triisopropylbenzenesulfonohydrazide, 95.0%, 25g

2-Hydroxy-terephthalic acid dimethyl ester, 95.0%, 25g

methyl 1-(2-bromophenyl)cyclopropane-1-carboxylate, 98%, 100mg

4-(2-Hydroxyethyl)piperazin-2-one, 95.0%, 250mg